volume 91, issue 4, P854-861 2014
DOI: 10.4269/ajtmh.14-0194
View full text
|
Sign up to set email alerts
|
Share

Abstract: A barrier to eliminating Plasmodium vivax malaria is inadequate treatment of infected patients. 8-Aminoquinoline–based drugs clear the parasite; however, people with glucose-6-phosphate dehydrogenase (G6PD) deficiency are at risk for hemolysis from these drugs. Understanding the performance of G6PD deficiency tests is critical for patient safety. Two quantitative assays and two qualitative tests were evaluated. The comparison of quantitative assays gave a Pearson correlation coefficient of 0.7585 with signific…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

5
83
1

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals